Literature DB >> 9764414

New quantitative methods for detection of feline parvovirus (FPV) and virus neutralizing antibody against FPV using a feline T lymphoid cell line.

Y Ikeda1, T Miyazawa, K Kurosawa, R Naito, S Hatama, C Kai, T Mikami.   

Abstract

Previously, we reported that a feline T lymphoid cell line, FL74 cells, was very sensitive to feline parvovirus (FPV) infection. In the present study, we developed new quantitative methods for detection of FPV and virus neutralizing antibody against FPV using FL74 cells. The methods presented here were very simple and applicable to both canine parvovirus and feline panleukopenia virus.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9764414     DOI： 10.1292/jvms.60.973

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN： 0916-7250            Impact factor:   1.267


  7 in total

1.  Pathogenic potential of canine parvovirus types 2a and 2c in domestic cats.

Authors:  K Nakamura; M Sakamoto; Y Ikeda; E Sato; K Kawakami; T Miyazawa; Y Tohya; E Takahashi; T Mikami; M Mochizuki
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Passive protection of dogs against clinical disease due to Canine parvovirus-2 by specific antibody from chicken egg yolk.

Authors:  Sa Van Nguyen; Kouji Umeda; Hideaki Yokoyama; Yukinobu Tohya; Yoshikatsu Kodama
Journal:  Can J Vet Res       Date:  2006-01       Impact factor: 1.310

3.  Monoclonal antibodies that distinguish antigenic variants of canine parvovirus.

Authors:  Masato Nakamura; Kazuya Nakamura; Takayuki Miyazawa; Yukinobu Tohya; Masami Mochizuki; Hiroomi Akashi
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

4.  Apoptosis in feline panleukopenia virus-infected lymphocytes.

Authors:  Y Ikeda; J Shinozuka; T Miyazawa; K Kurosawa; Y Izumiya; Y Nishimura; K Nakamura; J Cai; K Fujita; K Doi; T Mikami
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

5.  Development of a recombinase polymerase amplification assay with lateral flow dipstick for rapid detection of feline parvovirus.

Authors:  Zhao-Hua Wang; Xiao-Jia Wang; Shao-Hua Hou
Journal:  J Virol Methods       Date:  2019-06-16       Impact factor: 2.014

6.  Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology.

Authors:  Sayumi Shimode; Tetsushi Sakuma; Takashi Yamamoto; Takayuki Miyazawa
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

7.  A new approach to establish a cell line with reduced risk of endogenous retroviruses.

Authors:  Aiko Fukuma; Rokusuke Yoshikawa; Takayuki Miyazawa; Jiro Yasuda
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.